These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 11675828)

  • 41. The effects of combined thrombolytic and platelet inhibitor therapy on myocardial and microvascular perfusion.
    de Lemos J
    Md Med; 2001; Suppl():88-9. PubMed ID: 11434069
    [No Abstract]   [Full Text] [Related]  

  • 42. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percutaneous coronary intervention versus thrombolysis: the definite management of st elevation myocardial infarction.
    Martinez-Ojeda J; Martinez-Toro J
    Bol Asoc Med P R; 2005; 97(4):308-14. PubMed ID: 16599071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Thrombocyte IIb/IIIa receptor inhibitors--a new direction in antithrombotic therapy].
    Panchenko EP
    Ter Arkh; 1997; 69(9):66-71. PubMed ID: 9411833
    [No Abstract]   [Full Text] [Related]  

  • 45. The relations of major platelet receptor expression during myocardial infarction. Monitoring efficacy of GPIIb/IIIa inhibitors by measuring P-selectin?
    Serebruany VL; Gurbel PA
    Thromb Haemost; 1999 Feb; 81(2):314-6. PubMed ID: 10064014
    [No Abstract]   [Full Text] [Related]  

  • 46. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
    Moliterno DJ; Topol EJ
    Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156
    [No Abstract]   [Full Text] [Related]  

  • 47. Combination therapy for acute myocardial infarction: glycoprotein IIb/IIIa inhibitors plus thrombolysis.
    Cannon CP
    Clin Cardiol; 1999 Aug; 22(8 Suppl):IV37-43. PubMed ID: 10492852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction.
    Dobesh PP; Kasiar JB
    Pharmacotherapy; 2002 Jul; 22(7):864-88. PubMed ID: 12126220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination therapy with reduced-dose fibrinolytic and platelet GP IIb/IIIa receptor inhibitors: SPEEDing into GUSTO V.
    Lincoff AM
    J Invasive Cardiol; 2001 May; 13 Suppl A():16A-18A. PubMed ID: 11458014
    [No Abstract]   [Full Text] [Related]  

  • 50. [Anti thrombotic therapy after coronary thrombolysis].
    Tani S; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():484-8. PubMed ID: 12735020
    [No Abstract]   [Full Text] [Related]  

  • 51. [Intracoronary administration of the combined fibrinolytic therapy a in patient with acute myocardial infarction and end-stage coronary heart disease - a case report].
    Dziewierz A; Dudek D; Bartuś S; Legutko J; Dubiel JS
    Kardiol Pol; 2003 Jan; 58(1):45-8. PubMed ID: 14502303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet GPIIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies.
    Mahadevan VS; McCarty D; Adgey AA
    Eur Heart J; 2002 Oct; 23(19):1490-1. PubMed ID: 12242068
    [No Abstract]   [Full Text] [Related]  

  • 53. [Thrombolytic treatment of acute myocardial infarct. 1].
    Soares-Costa JT; Soares-Costa TJ; Gabriel HM
    Acta Med Port; 1998 May; 11(5):409-19. PubMed ID: 9951051
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycoprotein IIb/IIIa blockade and thrombolytics: early lessons from the SPEED and GUSTO IV trials.
    Califf RM
    Am Heart J; 1999 Jul; 138(1 Pt 2):S12-5. PubMed ID: 10385786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glicoprotein (GP) IIb/IIIa inhibitors for acute stroke treatment.
    Bogousslavsky J; Paciaroni M; Gallai V
    Clin Exp Hypertens; 2002; 24(7-8):603-10. PubMed ID: 12450235
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Facilitated PCI for ST segment elevation myocardial infarction.
    Young JJ
    J Invasive Cardiol; 2004 Sep; Suppl():4-9. PubMed ID: 23573663
    [No Abstract]   [Full Text] [Related]  

  • 57. From thrombolytic megatrials to clinical policy-making: facing the facts.
    Naylor CD; Armstrong PW
    Can J Cardiol; 1995 Jun; 11(6):472-6. PubMed ID: 7780867
    [No Abstract]   [Full Text] [Related]  

  • 58. [Future developments in thrombolytic therapy].
    Bode C; Runge MS
    Z Kardiol; 1993; 82 Suppl 2():187-90. PubMed ID: 8328201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acute myocardial infarction. A guide for North Carolina doctors.
    Williams ML; O'Meara JJ; Tate DA; Simpson RJ
    N C Med J; 1995 Aug; 56(8):390-7. PubMed ID: 7566193
    [No Abstract]   [Full Text] [Related]  

  • 60. Antiplatelet and antithrombin therapy.
    Fernández-Ortiz A; Jang IK; Fuster V
    Coron Artery Dis; 1994 Apr; 5(4):297-305. PubMed ID: 8044341
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.